Rui Jiang
Corporate Secretary bei JINKO SOLAR CO., LTD.
Profil
Rui Jiang currently works at Cali Biosciences Co. Ltd., as Non-Executive Director from 2021 and Jinko Solar Co., Ltd., as Secretary from 2021.
Mr. Jiang also formerly worked at Bloomage Biotechnology Corp.
Ltd., as Board Secretary, Director & Deputy General Manager from 2019 to 2020.
Mr. Jiang received his graduate degree in 2008 from Renmin University of China.
Aktive Positionen von Rui Jiang
Unternehmen | Position | Beginn |
---|---|---|
JINKO SOLAR CO., LTD. | Corporate Secretary | 07.01.2021 |
Cali Biosciences Co. Ltd.
Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Director/Board Member | 17.03.2021 |
Ehemalige bekannte Positionen von Rui Jiang
Unternehmen | Position | Ende |
---|---|---|
BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED | Director/Board Member | 25.12.2020 |
Ausbildung von Rui Jiang
Renmin University of China | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED | Process Industries |
JINKO SOLAR CO., LTD. | Electronic Technology |
Private Unternehmen | 1 |
---|---|
Cali Biosciences Co. Ltd.
Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Health Technology |